Ken Griffin's position in Genmab is currently worth $501k. That's 0.00% of their equity portfolio (3758th largest holding). The first Genmab trade was made in Q3 2019. Since then Ken Griffin bought shares 35 more times and sold shares on 25 occasions. The investor's estimated purchase price is $604k, resulting in a loss of 17%.